Target intelligence / Profile preview

RE1-silencing transcription factor (REST)

Target
REST
Molecular classification
Transcription factor, Kruppel-type zinc finger protein, Epigenetic regulator
01

Overview

RE1-silencing transcription factor (REST) is a Kruppel-type zinc finger transcription factor that acts as a master regulator of neuronal gene repression in non-neuronal cells and neural progenitors[1][3][6]. It binds to the RE1/NRSE (neuron-restrictive silencer element) DNA motif in target gene promoters, recruiting cofactors such as CoREST, mSin3A, HDACs, G9a, MECP2, and other chromatin modifiers to establish repressive chromatin, leading to transcriptional silencing[3][6][7]. REST is highly expressed in stem and progenitor cells and represses a broad array of neural genes, thus maintaining non-neuronal identity and modulating neurogenesis[7]. In mature neurons, REST is generally quiescent but can be upregulated in response to cellular stress (e.g., ischemia, seizures) and is implicated in neuronal injury or death in neurodegenerative and ischemic conditions[1][7]. Defective or aberrant REST function is associated with various cancers and several neurodegenerative disorders, underlining its importance as a disease-modifying and potentially therapeutic target[1][2].

Other names
Neuron-restrictive silencer factorNRSFX2 box repressorNeural-restrictive silencer factorDFNA27GINGF5HGF5WT6RE1 silencing transcription factorneuron-restrictive silencer factorrepressor binding to the X2 boxREST4
02

Mechanism of action

Inhibition of chromatin remodeling and transcriptional repression (e.g., HDAC inhibition counteracts REST-mediated gene silencing); RNA interference (RNAi) or dominant-negative (dn) REST proteins to block REST function

03

Biological functions

Transcriptional repression of neuronal genes in non-neuronal tissuesChromatin remodeling by recruitment of corepressors and chromatin-modifying enzymesRegulation of neurogenesis and maintenance of non-neuronal cell fateEpigenetic modification via histone deacetylation and methylationCell fate determination especially in neural developmentRegulation of neuronal differentiation and survival
04

Disease associations

Neurodegenerative disease (including Alzheimer’s disease and Huntington’s disease)Cancer (colon carcinoma, small-cell lung carcinoma, neuroblastoma)Ischemic brain injury (stroke)EpilepsyOther neurological disorders
05

Safety considerations

Potential for widespread gene dysregulation if REST is non-selectively targetedRisk of neurotoxicity or cell death due to REST’s critical regulatory role in neurogenesis and neuronal survivalAlterations could cause aberrant differentiation or apoptosis in developing or mature cells
06

Interacting drugs

No approved drugs are currently known to directly target REST, but agents such as histone deacetylase (HDAC) inhibitors (e.g., trichostatin A), and possibly gene therapy strategies (e.g., RNAi targeting REST), have been shown in research to modulate REST pathway activity[7].
07

Biomarkers

REST expression levels (elevated or decreased depending on disease context)Downstream target gene expression (e.g., GluA2, Nefh)Neuronal biomarkers influenced by REST, such as neurofilament heavy polypeptide (NEFH)

Beyond the preview

Go deeper on RE1-silencing transcription factor (REST).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RE1-silencing transcription factor (REST).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call